Hitachi Chemical Co., Ltd. and MD Anderson enter into strategic...
Hitachi Chemical Co., Ltd. and The University of Texas MD Anderson Cancer Center have entered into a four-year strategic alliance...
Making Cancer History® Seminar returns to Aspen July 22
The University of Texas MD Anderson Cancer Center heads to Aspen this summer for its 18th annual Making Cancer History® seminar. The...
Novel gene-hunting method implicates new culprit in...
Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into...
MD Anderson to host a national Cancer Moonshot Summit event June 29
The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot...
Shorter radiation course recommended for early-stage breast...
Early-stage breast cancer patients receiving a shorter course of whole breast radiation with higher radiation doses per fraction...
Antibody-based drug helps “bridge” leukemia patients to...
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute...
MD Anderson and Bristol-Myers Squibb announce new research...
HOUSTON and NEW YORK -- Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a new...
Progression-free survival triples in select metastatic lung...
ABSTRACT: 9004
Lung cancer patients with oligometastases, defined as three or fewer sites of metastasis, may benefit from...
MD Anderson researchers highlight advances in gynecologic...
ABSTRACTS: 5506, 5502, 1506
Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of...
Nivolumab immunotherapy helps patients with advanced...
ABSTRACT: 4501
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic...
Nivolumab shows promise in first-ever trial for patients...
ABSTRACT: 3503
In the first-ever clinical trial for metastatic patients previously treated for the disease, research led by The...
MD Anderson study identifies significant cost differences...
ABSTRACT: 6519
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of...